(Q24680126)

English

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease

scientific article

In more languages

Statements

scholarly article

0 references

A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (English)

0 references

0 references

0 references

Crohn's disease

0 references

1 reference

based on heuristic

inferred from title

14

object named as

P Rutgeerts

0 references

Jean-Frederic Colombel

4

object named as

J-F Colombel

0 references

author name string

W Reinisch

1

0 references

D W Hommes

2

0 references

G Van Assche

3

0 references

J-P Gendre

5

0 references

B Oldenburg

6

0 references

A Teml

7

0 references

K Geboes

8

0 references

H Ding

9

0 references

L Zhang

10

0 references

M Tang

11

0 references

M Cheng

12

0 references

S J H van Deventer

13

0 references

T Pearce

15

0 references

language of work or name

0 references

publication date

August 2006

0 references

0 references

55

0 references

8

0 references

1138-44

0 references

Inflammatory Bowel Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

7 April 2017

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

7 April 2017

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

7 April 2017

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

7 April 2017

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 September 2017

Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 September 2017

Biologic therapy of inflammatory bowel disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 September 2017

Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 September 2017

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 September 2017

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

30 May 2018

Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

30 May 2018

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

30 May 2018

Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

30 May 2018

Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

30 May 2018

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 November 2018

Risk factors for surgery and postoperative recurrence in Crohn's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1856289

28 November 2018

Epidemiology of inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-gamma-inducible chemokines enhance adaptive immunity and colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ expression of E-selectin and intercellular adhesion molecule-1 in chronic inflammatory diseases of the gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new measure of health status for clinical trials in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA antigens in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16492717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.2005.079434

0 references

release_vn5g3xxnjjatjf6qpljep2hixi

1 reference

https://api.fatcat.wiki/v0/release/vn5g3xxnjjatjf6qpljep2hixi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24680126&oldid=1840471767"